The power of proton therapy to destroy tumors while sparing normal tissue, a reality check on the safety of tests that use radiation to capture images of the body, and strategies for managing your medicines.
View current issue now »
Get the latest information about cancer care and research every month.
Obesity may overtake tobacco as the nation’s leading preventable cause of cancer, the FDA approves an immunotherapy drug tested at MSK, and tips on keeping your teeth and gums healthy during cancer treatment.
An experimental drug to turn certain types of blood cancer cells into normal cells shows promise, Wholeness of Life Award recipient Louis P. Voigt discusses his approach to patient care, and ways to make the holidays a time for meaningful moments at the end of life.
Researchers discover why the immunotherapy drug ipilimumab works for some people with melanoma and not others, a powerful genetic test helps doctors determine the best lung cancer treatment for MSK patients, and medical oncologist David Solit describes how basket trials are transforming cancer research.
Tips on ways to support a friend with cancer, the latest news in breast cancer care at MSK, and strategies from clinical nurse Kathryn Ciccolini on filling prescriptions efficiently and at the lowest cost possible.
New facilities provide easier access to MSK’s cancer care, medical oncologist Paul Hamlin describes our Oncology Clinic of the Future, and the latest information about our advances in treating Hodgkin and non-Hodgkin lymphoma.
Researchers discover a tropical plant that could block a cancer-causing gene, liquid biopsies are explored as an alternative to needle biopsies, and diagnostic radiologist Carol Lee answers follow-up questions about the impact of breast density on cancer risk.
U.S. News & World Report names Memorial Sloan Kettering the number one hospital in the nation for cancer care, we celebrate 130 years of progress in the quest to conquer cancer, and a singer diagnosed with tongue cancer talks about how our surgeons preserved her ability to continue performing.
- June 2014
Our expertise in cancer immunotherapy draws media attention at major medical meetings, advice on managing your career during cancer treatment and recovery, and new information about our expertise in treating thymoma and other thymic tumors.
- May 2014
A $100 million gift creates the Marie-Josée and Henry R. Kravis Center for Molecular Oncology to deliver on the promise of personalized medicine, physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy, and new information sheds light on why hundreds of people each year choose MSK for diagnosis and treatment of bladder cancer.
- April 2014
A discovery on how dividing cells use a “speed limit” to avoid genetic mistakes, tips for coping with treatment-related hair loss, updates in lung cancer care, and answers to some common questions about HPV and cancers of the head and neck.
- March 2014
Physician-in-Chief José Baselga is selected to lead the American Association for Cancer Research, a clinical psychologist gives advice on supporting a friend or loved one at the end of life, and experts describe the latest in genetic counseling, testing, and treatment for people with BRCA mutations.
- February 2014
Updates in breast cancer care, ways to tend to your faith and spirit in difficult times, advice on dating when you have cancer, and clues as to why obese kidney cancer patients usually fare better despite a higher rate of diagnosis.
- January 2014
Memorial Sloan Kettering shares in a $540 million Ludwig Cancer Research gift to fuel immunotherapy research, tips on how to confirm the contents of dietary supplements, and a new radiation technique improves breast cancer treatment.
- December 2013
Memorial Sloan Kettering partners with biotech start-up Juno Therapeutics to accelerate novel cancer immunotherapies, a transparent zebrafish sheds light on how tumors metastasize, and a specialist describes why fear of addition shouldn’t lead cancer patients to avoid painkillers.
- November 2013
Cancer biologist Joan Massagué is named director of the Sloan Kettering Institute, Fred’s Team goes the distance in the ING New York City Marathon, and our experts talk about research and treatment advances in pediatric cancer care.
- October 2013
Memorial Sloan Kettering helps to speed early-stage drug discovery and innovation through the Tri-Institutional Therapeutics Discovery Institute, Good Morning America co-host Robin Roberts attends our stem cell transplant celebration, and a tobacco cessation expert explains what we do and don’t know about electronic cigarettes.
- September 2013
The Memorial Sloan Kettering Cancer Alliance is announced with Hartford HealthCare as a first member, internationally recognized experts in thoracic surgery and oncology join the institution, and our experts share the latest information about multiple myeloma treatment.
- August 2013
Our Resources for Life After Cancer program supports cancer survivors, Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton talks about a proposal to change the definition of cancer, and our experts share the latest information about cervical cancer treatment.
- July 2013
A new online tool helps current and former smokers decide whether to be screened for lung cancer, Memorial Sloan Kettering is named one of the nation’s best hospitals for cancer care, and our multidisciplinary experts advance the treatment of low-grade (glial) brain tumors.
- June 2013
Researchers report on major advances in the treatment of metastatic eye and skin melanoma, U.S. News & World Report‘s 2013-2014 issue ranks Memorial Sloan Kettering as one of the nation’s best hospitals for pediatric cancer care, and TV anchor Robin Roberts reflects on her cancer experience.
- May 2013
Clinical Genetics Service Chief Kenneth Offit discusses ways for women to clearly assess their risk for breast and ovarian cancer, findings from a large genetic study could improve the diagnosis and treatment of aggressive endometrial cancer, and our experts pioneer treatments for advanced kidney cancer.
- April 2013
Medical oncologist Paul Sabbatini discusses advancing cancer treatment through clinical research, Physician-in-Chief José Baselga explains the latest findings in targeted therapy for breast cancer, and researchers report on how a single early PSA test can predict a man’s risk for aggressive prostate cancer.
- March 2013
Gynecology Service Chief Richard Barakat comments on a study indicating that women with ovarian cancer benefit from treatment at high-volume centers, researchers eradicate cancer in five patients with acute lymphoblastic leukemia, and scientists discover a molecule that targets proteins inside cancer cells.
- February 2013
Physician-scientist Charles Sawyers is a recipient of the inaugural $3 million Breakthrough Prize in Life Sciences, medical oncologist Mark Kris discusses Memorial Sloan Kettering’s partnership with IBM Watson and WellPoint to help assist medical professionals, and Good Morning America’s Robin Roberts returns to work after a stem cell transplant.
- January 2013
Memorial Sloan Kettering projects are listed among 2012’s top cancer advances, Stand Up To Cancer names two physician-scientists to an Immunology “Dream Team,” and a behavioral psychologist discusses cognitive changes associated with cancer treatment.
- December 2012
A breast cancer specialist discusses new findings on extending tamoxifen for breast cancer, President Obama names Memorial Sloan Kettering physician-scientist Charles Sawyers to the National Cancer Advisory Board, and our experts share the latest information about prostate cancer treatment.
- November 2012
Memorial Sloan Kettering’s Integrative Medicine Service presents a new About Herbs mobile app, researchers synthesize the vital biological molecule erythropoietin for the first time, and experts discuss managing anxiety about medical scans and procedures.
- September 2012
Internationally recognized physician-scientist José Baselga (left) will join Memorial Sloan Kettering from Massachusetts General Hospital, Memorial Sloan Kettering announces plans to build a new outpatient cancer treatment facility, and a targeted drug for prostate cancer receives FDA approval.
- August 2012
Memorial Sloan Kettering unveils Meet Our Experts tab on Facebook, stem cell transplant specialists discuss the procedure and becoming a donor, and two cancer survivors share their experiences.
- July 2012
Memorial Sloan Kettering launches On Cancer blog, doctors start a clinical trial involving stem cell therapy for beta-thalassemia, and the Pediatric Day Hospital Director talks about caring for children with cancer.
- June 2012
Prostate cancer experts share their perspective on new PSA screening recommendations, an ICU nurse practitioner talks about her work, and our experts share the latest information about lung cancer treatment.
- May 2012
A pulmonary specialist talks about new findings on lung cancer CT screening, two of our investigates are named to the National Academy of Sciences, and the Bridges newsletter for cancer survivors marks its fifth year of publication.
- April 2012
The Department of Surgery Chair discusses surgery’s vital role in treating cancer, industry experts nominate mskcc.org for a Webby Award, and four surgeons describe what motivates them in their work.
- March 2012
Doctors describe training the next generation of cancer specialists, Memorial Sloan Kettering and IBM announce a collaboration using Watson technology, and researchers report pediatric cancer findings.
- February 2012
Scientists and physicians describe the promise of treating cancer with cell-based therapies, Cycle for Survival participants break fundraising records, and a neurosurgeon talks about innovations at the Spine Tumor Center.
- January 2012
Experts describe the development and commercialization of research discoveries to generate better cancer treatments, the American Society of Clinical Oncology elects medical oncologist Clifford Hudis as president, and our experts share the latest information about melanoma treatment.